ABclonal Technology, Inc.
United States of America (USA)
1 April 2019 - 31 March 2020
Region: Global
Subject/journal group: All
The table to the right includes counts of all research outputs for ABclonal Technology, Inc. published between 1 April 2019 - 31 March 2020 which are tracked by the Nature Index.
Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.
Note: Articles may be assigned to more than one subject area.
| Count | Share |
|---|---|
| 1 | 0.06 |
Outputs by subject (Share)
| Subject | Count | Share | |
|---|---|---|---|
| Life Sciences | 1 | 0.06 | |
| Chemistry | 1 | 0.06 | |
Top articles by Altmetric score in current window
MERTK mediated novel site Akt phosphorylation alleviates SAV1 suppression
Nature Communications
2019-04-03
1 April 2019 - 31 March 2020
International vs. domestic collaboration by Share
- 88.33% Domestic
- 11.67% International
Note: Hover over the graph to view the percentage of collaboration.
Top 10 domestic collaborators by Share (2 total)
- ABclonal Technology, Inc., United States of America (USA)
- Domestic institution
Top 10 international collaborators by Share (1 total)
- ABclonal Technology, Inc., United States of America (USA)
- Foreign institution
Note: Collaboration is determined by the fractional count (Share), which is listed in parentheses.
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
